SGZ analysis of tumor NGS data indicated high rates of biallelic inactivation for BRCA1/2 mutations, suggesting that loss of BRCA1/2 function is an early event in the progression of ovarian cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.